Time Course of Growth Differentiation Factor-15 levels in Post-Resuscitation-Shock after Out-of-hospital Cardiac Arrest

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background: Shock is a major contributor to the poor prognosis of patients after out-of-hospital cardiac arrest (OHCA). This study investigated whether serial levels of growth differentiation factor (GDF)-15 may serve as a marker for impaired cardiovascular function in OHCA survivors. Methods: This prospective single-center study included 42 adult OHCA patients who were admitted to a tertiary university hospital. Blood was collected from each patient on day 0 (admission), and on days 1, 2, 3 and 5 after ROSC. Serum GDF-15 and NT-proBNP were measured by ELISA and compared to serum levels of 42 patients with coronary artery disease (CAD). Serial GDF-15 levels and a number of outcomes were assessed, including heart failure biomarker (NT-proBNP), left ventricular ejection fraction (LVEF), acute myocardial infarction (AMI)-related OHCA, hemodynamic instability and lactate clearance. Results: Compared to CAD controls, serum GDF-15 levels were consistently elevated from admission to day 5 in OHCA patients. Elevated GDF-15 levels in OHCA patients correlated positively with NT-proBNP levels on day 1, 3 and 5 after ROSC. OHCA patients with LVEF<40% on admission had significantly higher GDF-15 levels than those with LVEF≥40%. Patients with acute myocardial infarction (AMI)-related OHCA had higher GDF-15 levels than patients with non-AMI causes of OHCA. In addition, patients with inadequate lactate clearance and increased and prolonged need for vasopressor/inotropic support, indicating hemodynamic instability, had significantly elevated GDF-15 levels. Conclusion: Elevated GDF-15 levels are associated with AMI-related OHCA and key determinants of impaired cardiovascular function. Therefore, GDF-15 levels facilitate the identification of patients with post-resuscitation shock who require aggressive treatment. Trial Registration: German Clinical Trials Register DRKS; DRKS00009684; registered 27 November 2015; https://drks.de/search/de/trial/DRKS00009684

Article activity feed